The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Postmenopausal Osteoporosis Treatment Global Market Report 2023, The global postmenopausal osteoporosis treatment market is expected to grow from $8.80 billion in 2022 to $9.49 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The postmenopausal osteoporosis treatment market is expected to reach $11.63 billion in 2027 at a CAGR of 5.2%.

What was the major driver in the postmenopausal osteoporosis treatment market?

The increasing prevalence of osteoporosis is expected to propel the growth of the postmenopausal osteoporosis treatment market going forward. Osteoporosis is a medical disorder resulting in decreased bone mass and deteriorated bone tissue, increasing weakness, and fracture risk. Postmenopausal osteoporosis treatment helps prevent or manage the condition and reduces the risk of fractures, improving the quality of life and overall health outcomes for affected individuals. For instance, in September 2022, according to Healthy Bones Australia, an Australia-based non-governmental organization, the number of fractures caused by osteoporosis or osteopenia increased from 178,439 fractures in 2021 to 183,105 in 2022. Therefore, the increasing prevalence of osteoporosis is driving the growth of the postmenopausal osteoporosis treatment market.

View More On The Postmenopausal Osteoporosis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/postmenopausal-osteoporosis-treatment-global-market-report

What was the key trend in the postmenopausal osteoporosis treatmentmarket?

Product innovations are a key trend gaining popularity in the postmenopausal osteoporosis treatment market. Major companies operating in the postmenopausal osteoporosis treatment market are innovating new products to sustain their position in the market. For instance, in January 2021, Theramex, a UK-based pharmaceutical company, launched Livogiva, specifically designed for patients with osteoporosis. It increases the number of medications in our expanding line-up for treating osteoporosis at all stages, from prevention with calcium and vitamin D to current treatments, which include a next-generation oral bisphosphonate with patient-friendly administration instructions.

Which was the largest region in the postmenopausal osteoporosis treatment market?

North America was the largest region in the postmenopausal osteoporosis treatment market in 2022. The regions covered in the postmenopausal osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the postmenopausal osteoporosis treatmentmarketprominent players?

Major players in the postmenopausal osteoporosis treatment market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Fresenius Kabi AG, Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr. Ready’s Laboratories Ltd., Hikma Pharmaceuticals PLC., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Takeda Pharmaceutical Company Limited, Lupin Limited, Celltrion Inc., Biocon Limited, Accord Healthcare Ltd, Ligand Pharmaceuticals Incorporated, and Torrent Pharmaceuticals Limited.

Key postmenopausal osteoporosis treatmentmarket segments

The global postmenopausal osteoporosis treatment market is segmented –

1) By Drug Type: Bisphosphonates, Vitamin D3, Estrogen Agonist Or Antagonist, Hormone Replacement Therapy, Parathyroid Hormone Therapy, Other Drug Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

RequestA Sample Of The Global Postmenopausal Osteoporosis Treatment Market Report 2023:

https://www.thebusinessresearchcompany.com/sample_request?id=12680&type=smp

The Postmenopausal Osteoporosis Treatment Global Market Report 2023 provides a comprehensive overview on the postmenopausal osteoporosis treatment market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –

Osteoporosis Drugs Global Market Report 2023

Hyperphosphatemia Treatment Global Market Report 2023

Osteoporosis Treatment Global Market Report 2023

 Contact us at:

The Business Research Company:https://www.thebusinessresearchcompany.com/

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Email us at [email protected]

Follow us on:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
YouTube:https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model:https://www.thebusinessresearchcompany.com/global-market-model